Sinocelltech Group Limited (SHA:688520)

China flag China · Delayed Price · Currency is CNY
44.25
-0.76 (-1.69%)
Apr 17, 2026, 3:00 PM CST
Market Cap20.81B +18.7%
Revenue (ttm)1.56B -37.9%
Net Income-553.29M
EPS-1.29
Shares Out470.34M
PE Ration/a
Forward PE47.07
Dividendn/a
Ex-Dividend Daten/a
Volume4,036,221
Average Volume3,941,352
Open44.50
Previous Close45.01
Day's Range43.91 - 45.60
52-Week Range35.20 - 89.04
Beta0.73
RSI60.50
Earnings DateApr 23, 2026

About Sinocelltech Group

Sinocelltech Group Limited, a biopharmaceutical company, engages in the research, development, and production of recombinant proteins, antibody drugs, and vaccines in China. The company offers Anjiayin, a third-generation recombinant coagulation factor VIII product for the treatment of hemophilia A; Anpingxi, an anti-CD20 monoclonal antibody for the treatment of CD20-positive diffuse large B-cell non-Hodgkin's lymphoma; Anjiarun, an adalimumab biosimilar for the treatment of various autoimmune diseases; Anbezu, a bevacizumab biosimilar for the ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 2,242
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688520
Full Company Profile

Financial Performance

Financial Statements